Cant go back far enough to find more than one referral to non-clinical work on additional indications. That only refers to " multiple undisclosed indications " . Even if it is only 2 interesting indications worthy of progressing this leaves us potentially three p3 trials, 1 p2 completion plus p3 , and 2 (+) undisclosed indications through the whole process. Yes?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)